Moore MA 1 Curriculum Vitae: Malcolm Anthony MooreMoore MA 1 Curriculum Vitae: Malcolm Anthony Moore Nationality: British Age:61 Born: SouthShields,England 8.12.1951 Family Status:

Moore MA 1

Curriculum Vitae: Malcolm Anthony Moore

Nationality: British Age: 61 Born: South Shields, England 8.12.1951

Family Status: Married with two children

Address: 4-84 Joto-cho, Kita-ku, Nagoya 462-0831, Japan Tel 052-915-1385Email: [email protected]@yahoo.com

OccupationHead (until 28.7.2012), UICC Asia Regional Office, Bangkok, ThailandPublication member (from 28.7.2012), UICC Asia Regional Office, TokyoEditor-in-Chief, Asian Pacific Journal of Cancer PreventionManaging Director, APE Press Co., Ltd

EducationSept 1969 - July 1973

Sept 1976 - Aug 1979

Leeds University School of Science (graduated, B.Sc.)Dept of ZoologyBristol University Graduate School of Medicine (completedPh.D.) Dept of Pathology

DegreesB.Sc.HonsPhD

Leeds University, July 1973Bristol University, January, 1980

EmploymentSep 1979 - Mar 1983 Research Fellow, German Cancer Research Centre

Dept of CytopathologyApr 1983- Mar 1986 Assistant Professor, Department of Pathology, Nagoya City

University School of MedicineApr 1986- Dec 1986 Research Fellow, Japanese Foundation for Cancer Research

Cancer Institute, Dept Exp PathologyJan 1987 - Jul 1988 Acting Chief, Carcinogenesis Research Unit, Dept of Pathology

University of New SouthWales, SydneyJul 1988 - Dec 1988 Research Fellow, German Cancer Research Centre

Dept of CytopathologyJan 1989 - Dec 1990 Assistant Professor, Nagoya City University School of Medicine

Department of PathologyJan 1991 - Mar 1997 Director, Intermal Scientific Language, NagoyaApr 1997 - Mar 1999 Guest Scientist, National Cancer Center, Tokyo

Department of Chemotherapy and Exp PathologyApr 1999 - Mar 2002 Director, Intermal Scientific Language, Nagoya

Coordinator, Asian Pacific Organization for Cancer Prevention,Bangkok

Apr 2002 - Mar 2004 Guest Scientist, National Cancer Center, TokyoDepartment of Chemotherapy and Exp Pathology

Apr 2004 - Apr 2005 Director, Intermal Scientific Language, NagoyaCoordinator, Asian Pacific Organization for Cancer Prevention,

MooreMA2

Oct 2006 - Dec 2012Oct 2006 - presentOct 2008 - Mar 2009

BangkokResearch Fellow, Kyushu UniversityDept of Preventive MedicineHead, UICC Asia Regional Office, BangkokChief Editor, APJCP, APOCP CoordinatorGuest Scientist, National Cancer Center, TokyoDepartment of Cancer InformationInternational Adviser, National Cancer Center, KoreaManaging Director, APE Press Co. Ltd.

Apr 2005 - Sep 2006

Apr 2010 - Mar 2011Mar 2013 - present

Experience and Aims

In 1999, with a long research career in toxicological pathology behind me, Idecided with a number of colleagues to establish an international organization topromote cancer prevention in the countries of Asia, the result being the Asian PacificOrganization for Cancer Prevention (APOCP) and its official journal the Asian PacificJournal of Cancer Prevention (APJCP).

Following production of an IntroductoryVolume, the journal was issued firstas a quarterly for nine years then bimonthly in 2010, and monthly in 2011/2012, withmyself as the individual responsible for practical aspects of publication. The journal isindexed on PubMed and all the papers are freely available as pdf files from ourwebsite (www.apjcpcontrol.org).Itis also on the Science Citation Index (Expanded)list of journals with an Impact Factor for 2010 of 1.24 and for 2011 of 0.66.

From 2006 until very recently I was employed as Head of the UICC, AsianRegional Office, with the task of assisting where possible in promoting cancer controlactivities in the Asian-Pacific while acting as Chief Editor of the APJCP. This hasincluded assisting other organizations in staging cancer congresses, including theICCC-4 in November 2011, the 6th APOCP General Assembly in April 2012 and anumber of Conferences to be staged in 2013 and 2014. Now my main activity isfocused on the journal, primarily because of the increase in work burden with risingsubmissions. In addition, as adjunct Professor I continue to lay stress on teachingcommitments in the area of epidemiology research and scientific English languageuse, most recently in Astana Medical University, Kazakhstan, and Khon KaenUniversity, Thailand.

Publication List

Moore MA (2012). Update on the APJCP and the APOCP in 2013 - What is Going tobe Achieved in the Future? Asian Pac J Cancer Prev, 14,2151-3.

Igissinov S, Igissinov N, Moore MA, Kozhakhmetov S, Igissinova G, Sarsenova S,Aldiyarova G, Bilyalova Z, Zhabagin K, Manambayeva Z. (2013). Componentanalysis of esophageal cancer incidence in Kazakhstan.Asian Pac JCancer Prev, 14,1945-9.

- -_._----

MooreMA3Saranrittichai K, Senarak W, Promthet S, Wiangnon S, Vatanasapt P, Kamsa-ard S,

Wongphuthorn P, Moore MA (2012). Health behavior after a multiprofessionalintervention and training for ongoing volunteer-based community healthprogramme intervention in the North-East of Thailand: what changed and whatnot? Asian Pac J Cancer Prev, 13,4801-5.

Igissinov N, Nuralina I, Igissinova G, Kim S, Moore MA, Igissinov S, Khassenova Z .(2012). Epidemiological aspects of morbidity and mortality from cervical cancer inKazakhstan. Asian Pac J Cancer Prev, 13, 2345-8.

Bilyalova Z, Igissinov N, Moore MA, Igissinov S, Sarsenova S, Khassenova Z (2012)Epidemiological evaluation of breast cancer in ecological areas of Kazakhstan -association with pollution emissions. Asian Pac J Cancer Prev, 13, 2341-4.

Igissinov S, Igissinov N, Moore MA, Kalieva Z, Kozhakhmetov S (2012).Epidemiology of esophageal cancer in Kazakhstan. Asian Pac J Cancer Prev, 13,833-6.

Igissinov N, Igissinov S, Moore MA, Shaidarov M, Tereshkevich D, Bilyalova Z,Igissinova G, Nuralina I, Kozhakhmetov S (2011). Trends of prevalent cancerincidences in the Aral-Syr Darya ecological area of Kazakhstan. Asian Pac JCancer Prev, 12,2299-303.

Promthet S, Saranrittichai K, Kamsa-ard S, Senarak W, Vatanasapt P, Wiangnon S,Wongphuthorn P, Moore MA (2011). Situation analysis of risk factors related tonon-communicable diseases in Khon Kaen Province, Thailand. Asian Pac J CancerPrev, 12, 1337-40.

Moore MA, Yip CH, Y00 KY (2011). New Developments to Report for the APJCPand the APOCP. Asian Pac J Cancer Prev, 12, 1-2.

Han MA, Choi KS, Park JH, Moore MA, Park EC (2011) Midcourse Evaluation ofthe Second-term 1O-year Plan for Cancer Control in Korea. Asian Pac J CancerPrev 12, 327-33.

Salim EI, Jazieh AR, Moore MA (2011). Lung cancer incidence in the Arab leaguecountries: risk factors and control. Asian Pac J Cancer Prev, 12, 17-34.

Bener A, Moore MA, Ali R, EI Ayoubi HR (2010). Impacts of family history andlifestyle habits on colorectal cancer risk: a case-control study in Qatar. Asian Pac JCancer Prev, 11, 963-8.

Moore MA, Yoo K-Y, Tuncer M, Sobue T (2010). Overview of players andinformation in the cancer epidemiology world in Asia. Asian Pac J Cancer Prev,11Suppll, 1-10.

Moore MA, Eser S, Igisinov N, Igisinov S, Mousavi-Jarrahi A, Mohaghegi MA,Ozenturk G, Tuncer M, Sobue T (2010). Cancer epidemiology in North-Western

MooreMA4and Central Asia - past, present and future. Asian Pac J Cancer Prev, 11 Suppll,15-32.

Salim EI, Moore MA, Bener A, Habib OS, Seif-Eldin IA-B, Sobue T (2010). Cancerepidemiology in South-Western Asia - past, present and future. Asian Pac JCancer Prev, 11 Suppll, 33-48.

Moore MA, Sobue T Malcolm A Moore, Yasantha Ariyaratne, Farhana Badar,Yasmin Bhurgri, Karabi Datta, P Gangadharan, Aleyamma Mathew, ANandakumar, Kishore K Pradhananga, Md Habibullah Talukder, Balkrishna BYeole (201O).CancerEpidemiology in South Asia - past, present and future. AsianPac J Cancer Prev, 11 Suppll, 49-66.

Moore MA, Attasara P, Khuhaprema T, Ngoan LT, Nga NTH, Sriplung H,Srivanatanakul P, Promthet S, Tung BD, Wiangnon S, Sobue T (2010). Cancerepidemiology in Mainland South-East Asia - past, present and future. Asian Pac JCancer Prev, 11 Suppll, 67-80.

Moore MA, Manan AA, Chow KY, Cornain SF, Devi CRB Ediati Triningsih FX,Laudico A, Mapua CA, Mirasol-LumagueMR, Othman NH, Shah SA, SinurayaES, Soeripto, Yip CH, Sobue T (2010). Cancer epidemiology in Peninsular andIsland South-East Asia - past, present and future.Asian Pac J Cancer Prev, 11Suppll,81-98.

Moore MA, Baumann F, Foliaki S, Goodman MT, Haddock R, Maraka R, KoroivuetaJ, Roder D, Vinit T, Whippy H, Sobue T (2010). Cancer epidemiology in the PacificIslands - past, present and future. Asian Pac J Cancer Prev, 11 Suppll, 99-106.

LongN, Moore MA, Chen WQ, Gao C-M, Mizoue T, Oyunchimeg D, Park SH, ShinH-R, Tajima T, Yoo K-Y, Sobue T (2010). Cancer epidemiology in North-East Asiapast, present and future. Asian Pac J Cancer Prev, 11 Suppll, 107-148.

Moore MA, Sobue T (2010).Measures for cancer control on an organ-site basis. AsianPac JCancer Prev, 11 Suppll, 149-164.

Tanaka H, Tanaka M, Chen W, Park S, Jung KW, Chiang CJ, Lai MS,Mirasol-Lumague MR, Laudico AS, Sinuraya ES, Nishino Y, Shibata A, Fujita M,Soda M, Naito M, Tsukuma H, Moore MA, Ajiki W (2009). Proposal for acooperative study on population-based cancer survival in selected registries in EastAsia. Asian Pac J Cancer Prev, 10, 1191-8.

Moore MA, Aitmurzaeva G, Arsykulov ZA, Bozgunchiev M, Dikanbayeva SA,Igisinov G, Igisinov N, Igisinov S, Karzhaubayeva S, Oyunchimeg D, Oyunsuren T,Soipova M, Tumubaatar T (2009). Chronic disease prevention research in centralAsia, the Urals, Siberia and Mongolia - past, present and future. Asian Pac JCancerPrev, 10, 987-96.

Moore MA (2009). Diverse influences of dietary factors on cancer in Asia. Asian PacJCancer Prev, 10, 981-6.

MooreMA5

Bener A, EI Ayoubi HR, Moore MA, Basha B, Joseph S, Chouchane L (2009). Do weneed to maximise the breast cancer screening awareness? Experience with anendogamous society with high fertility. Asian Pac J Cancer Prev, 10, 599-604.

Moore MA, Sobue T (2009). Cancer research and control activities in Japan:contributions to international efforts.Asian Pac J Cancer Prev, 10, 183-200.

Moore MA (2009). Members responses regarding the future of the APOCP(C) andAPJCP(C). Asian Pac J Cancer Prev, 10, 181-2.

Salim EI, Moore MA, Al-Lawati JA, Al-Sayyad J, Bazawir A, Bener A, Corbex M,EI-SaghirN, Habib OS, Maziak W, Mokhtar HC, Seif-Eldrin lA, Sobue T (2009).Cancer epidemiology and control in the arab world - past, present and future. AsianPac JCancer Prev, 10, 3-16.

Moore MA, Yoo KY, Tuncer M (2009). What is the future for the Asian PacificJournal of Cancer Prevention (and Control) and the Asian Pacific Organization forCancer Prevention (and Control)? Asian Pac J Cancer Prev, 10, 1-2.

Moore MA, Shin HR, Curado MP, Sobue T (2008). Establishment of an Asian CancerRegistry Network - problems and perspectives. Asian Pac J Cancer Prev, 9, 815-32.

Ngoan Ie T, Khan NC, Mai le B, Huong NT, Thu NT, Lua NT, Hang LT, Bich NN,Hieu NV, Quyet HV, Tai le T, Van do D, Moore MA, Tokudome S, Yoshimura T(2008). Development of a semi-quantitative food frequency questionnaire fordietary studies-focus on vitamin C intake.Asian Pac J Cancer Prev, 9, 427-32.

Moore MA (2008). Prevention of life-style related diseases in Sri Lanka.Asian Pac JCancer Prev, 9, 367-70.

Moore MA, Tajima K (2008). The APJCP as the official journal of the UICC-AsianRegional Office for Cancer Control and the Asian Pacific Organization for CancerPrevention and Control. Asian Pac J Cancer Prev, 9, 163-4.

Tokudome S, Ando R, Ghadimi R, Tanaka T, Hattori N, Yang Z, Marumoto M,Agawa H, Arakawa K, Osaka Y, Tanaka H, Hosono A, Moore MA (2007). Arethere any real Helicobacter pylori infection-negative gastric cancers in Asia? AsianPac J Cancer, 8, 462-3.

Wiangnon S, Sriamporn S, SenarakW, Saranrittichai K, Vatanasapt P, Moore MA.(2007). Use of lay health workers in a community-based chronic disease controlprogram. Asian Pac J Cancer Prev, 8, 457-61.

Yoshida D, Kono S, Moore MA, Toyomura K, Nagano J, Mizoue T, Mibu R, TanakaM, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, MaekawaT, Takenaka K, Ichimiya H, Imaizumi N (2007). Colorectal polypectomy and risk of

MooreMA6colorectal cancer by subsite: the Fukuoka Colorectal Cancer study. Jpn J ClinOneal, 37,597-602.

Nanri A,Moore MA, Kono S (2007). Impact of C-reactive protein on disease risk andits relation to dietary factors. Asian Pac J Cancer Prev, 8, 167-77.

Yin G, Kono S, Toyomura K,Moore MA, Nagano J, Mizoue T, Mibu R, Tanaka M,Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, Maekawa T,Takenaka K, Ichimiya H, Imaizumi N (2007). Alcohol dehydrogenase and aldehydedehydrogenase polymorphisms and colorectal cancer: the Fukuoka ColorectalCancer Study. Cancer Sci, 98, 1248-53

Akaza H,Moore MA, Chang SJ, Cheng C, Choi HY, Esuvaranathan K, Hinotsu S,Hong SJ, Kim CS, Kim WJ, Murai M, Naito S, Soebadi D, Song JM, Umbas R,Usami M, Xia S, Yang CR (2007). The 5th Conference on Asian Trends in ProstateCancer Hormone Therapy.Asian Pac J Cancer Prev, 8, 3-12.

Kimura Y, Kono S, Toyomura K, Nagano J, Mizoue T, Moore MA, Mibu R, TanakaM, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, MaekawaT, Takenaka K, Ichimiya H, Imaizumi N (2007). Meat, fish and fat intake in relationto subsite-specific risk of colorectal cancer: The Fukuoka Colorectal Cancer Study.Cancer Sci, 98, 590-7.

Cheng C, Akaza H, Chen KK,Moore MA, Naito S, Song JM, Umbas R, Xia S; UICCARO Prostate Cancer Consortium (2006) Prostate cancer control=aims of the UICCAsia Regional Office Consortium.Asian Pac J Cancer Prev, 7, 350-68.

Tokudome S, Ghadimi R, Suzuki S, Hosono A, Tanaka T, Arakawa K, Zhao Y,Hattori N, Agawa H, Marumoto M, Ando R, Moore MA (2006). Helicobacterpylori infection appears the prime risk factor for stomach cancer. Int J Cancer, 15,119.

Isomura K, Kono S,Moore MA, Toyomura K, Nagano J, Mizoue T, Mibu R, TanakaM, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, MaekawaT, Takenaka K, Ichimiya H, Imaizumi N. (2006). Physical activity and colorectalcancer: the Fukuoka Colorectal Cancer Study.Cancer Sci, 97, 1099-104.

Ueda S, Fukamachi K, Matsuoka Y, Takasuka N, Takeshita F, Naito A, Iigo M,Alexander DB, Moore MA, Saito I, Ochiya T, Tsuda H (2006).Ductal origin ofpancreatic adenocarcinomas induced by conditional activation of a human Ha-rasoncogene in rat pancreas. Carcinogenesis, 27, 2497-510.

Moore MA (2006). Do cross-registry comparisons of black and white Americansprovide support for N-acetylation as an important determinant for bladder and othertobacco-related cancers? Asian Pac J Cancer Prev, 7, 267-73.

Moore MA and Tsuda H (2006). Chemoprevention - how feasible? Asian Pac JCancer Prev, 7, 165-6.

MooreMA 7

Moore MA and Tajima K (2006). Practical cancer prevention - where is it going tooccur and who is going to be responsible? Asian Pac J Cancer Prev, 7, 1-2.

Moore MA and Tajima K (2006). Overview of existing networks. Is there a rationalefor an Asian Cancer Registry Network? Asian Pac J Cancer Prev, 7, 157-60.

Moore MA (2005). APJCP report - the situation after six years.Asian Pac J CancerPrev, 6, 423-4.

Moore MA, Sobue T, Tajima K, and Kono S (2005). What do cancer registry andhousehold expenditure data in Japan tell us about variation in tumour burden. AsianPac J Cancer Prev, 6, 427-36.

Moore MA, Sobue T, Kuriki K, Tajima K, Tokudome S. and Kono S (2005).Comparison of Japanese, American-Whites and African-Americans--pointers to riskfactors to underlying distribution of tumours in the colorectum. Asian Pac J CancerPrev, 6, 412-9.

Moore MA (2005). Asian collaboration across cancer registries. Asian Pac J CancerPrev, 6, 235-6.

Moore MA (2005). Traffic air pollution -- is it safe to be a traffic policeman orprofessional driver? Asian Pac J Cancer Prev, 6, 107-9.

Tokudome S, Soeripto, Triningsih FX, Ananta I, Suzuki S, Kuriki K, Akasaka S,Kosaka H, Ishikawa R, Azuma T, Moore MA (2005). Rare Helicobacter pyloriinfection as a factor for the very low stomach cancer incidence in Yogyakarta,Indonesia. Cancer Lett, 219, 57-61.

Tokudome S, Nahomi I, Goto C, Tokudome Y, Moore MA (2005). Black tea andcardiovascular disease. Int J Epidemiol., 34, 482-3

Moore MA (2005). Arguments for coordination of primary and secondary preventionfor breast cancer? Asian Pac J Cancer Prev, 6, 1-3.

Moore, MA and Tajima, K (2004) Cervical cancer in the Asian Pacific -epidemiology, screening and treatment. Asian Pacific J Cancer Prev, 5,349-361.

Moore, MA and Tajima, K. (2004) Publishing the APJCP - open access and whoshould pay? An aside to the financial report for the 2nd APOCP General AssemblyConference.Asian Pacific J Cancer Prev, 5, 341-344.

Tsuda, R., Ohshima, Y., Nomoto, R., Fujita, K., Matsuda, E., Iigo, M., Takasuka, N.and Moore M.A. (2004) Cancer prevention by natural compounds. Drug MetabPharmacokinet., 19,245-63.

MooreMA8

Moore, MA and Tajima, K.(2004) We are what we eat--but what do we eat?--A rolefor coordination of cancer registration and dietary intake. Asian Pacific J CancerPrev, 5, 229-230.

Tokudome, S., Kuriki, K., Suzuki, S., Akasaka, S., Kosaka, H., Ishikawa, H.,Yoshimura, T., Azuma, T., Due Van, D., Cong Khan, N., Sriampom, S., Wiangnon,S., Soeripto, Triningsih, F.E. and Moore MA. (2004) Re: helicobacter pyloriinfection and gastric cancer: facing the enigmas. Int J Cancer, 112, 166-7

Moore, M.A., Tsuda, H. and Tajima, K.(2004) Awareness and high relative mortalityrates in the Asian Pacific. Asian Pacific JCancer Prev, 5,91-93.

Tokudome, S., Tokudome, Y., Goto, C., Suzuki, S. and Moore, MA (2004). Seaweedas a beneficial iodine food source.Asian Pacific J Cancer Prev, 5,89.

Iigo, M., Shimamura, M., Matsuda, E., Fujita, K., Nomoto, H., Satoh, r.,Kojima, S.,Alexander, D.B., Moore, M.A. and Tsuda H. (2004) Orally administered bovinelactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: apossible explanation for inhibition of carcinogenesis and metastasis. Cytokine, 25,36-44.

Moore, M.A. and Tsuda, H. (2003) Can risk assessment and chemopreventionresearch rely on surrogates for tumour yield?Asian Pac J Cancer Prev, 4, 167-8.

Moore, M.A., and Tsuda, H. (2003) A Practical Guide to the Use of Scientific English- A Skeleton Approach. APE Press Ltd, Nagoya and Bangkok.

Moore, M.A., Tajima, K., Anh, P.H., Aydemir, G., Basu, P.S., Bhurgri, Y., Chen, K.,Gajalakshmi, V., Hirose, H., Mosavi-Jarraji, A., Ngoan, L.T., Qiao, Y-L., ShinH.R., Sriampom, S., Srivatanakul, P., Tokudome, S., Yoo, x-v. and Tsuda, H.(2003) Grand challenges in global health and the practical prevention program?Asian focus on cancer prevention in females of the developing world. Asian PacificJCancer Prev, 4, 153-165.

Chaimuangraj, S., Thamavit, W., Tsuda, H., Moore, M.A. (2003) Experimentalinvestigation of opisthorchiasis-associated cholangiocarcinoma induction in theSyrian hamster - pointers for control of the human disease. Asian Pac J CancerPrev, 4,87-93.

Moore, M.A., Qiao, Y-L., Threlfall, TJ., Tokudome, S., Tsuda, H. and Tajima, K.(2003) The APOCP/APJCP - Taking stock and planning for the future. AsianPacific J Cancer Prev, 4, 79-80.

Fukushima, S., Tsuda, H. and Moore, M.A. (2003) Appropriate models and anunderstanding of carcinogenic mechanisms - requirements for risk assessment.Asian Pacific J Cancer Prev, 4, 75-78.

MooreMA9

Moore,M.A., Kunimoto,T. and Tsuda, H. (2003) Cancer screening literature in theperiod 2000-2002 : Pointers to future research avenues. Asian Pacific J CancerPrev, 4, 57-60.

Moore, M.A., and Tsuda, H. (2003). Targeting the workplace for cervical andmammary cancer screening? Asian Pacific J Cancer Prev, 4, 1-2

Tsuda H, Naito A, Kim CK, Fukamachi K and Moore, M.A. (2003) Carcinogenesisand its modification by environmental endocrine disruptors - in vivo experimentaland epidemiological findings. Jpn J Clin Oncol, 33, 259-270.

Tsuda, H., Fukushima, S., Nakae, D., Imaida, K., Tatematsu, M., Hirose, M., Otani,S., Wakabayashi, K., Moore, M.A. (2003) Value of GST-P positive preneoplastichepatic foci in dose-response studies ofhepatocarcinogenesis: evidence forthresholds with both genotoxic and non-genotoxic carcinogens. Toxicol Pathol ,31,80-86.

Moore M.A., Tajima, K. and Tsuda, H. (2003). Epidemiology of the major cancers inthe Asian Pacific. Proc Jpn Acad, 79. 27-33.

Doungchawee, G., Khoaprasert, Y., Kongtim, S., Thamavit, W., Tajima, K., Moore,M.A. and Tsuda H. (2002) Use of wild rodents for environmental monitoring­comparison ofrats in Bangkok and rural areas of Thailand. Asian Pac J CancerPrev, 3, 367-368.

Moore, M.A., and Tsuda, H. (2002). Smoking-related research in the Asian-Pacificcountries. Asian Pacific J Cancer Prev, 3, 291-304

Moore, M.A. and Tsuda, H. (2002). Food and play preferences - does cancerprevention require targeting the child? Asian Pacific J Cancer Prev, 3, 279-280.

Moore, M.A. and Tajima, K (2002) Coordinated research and the question of anIARC for the Asian-Pacific? Asian Pacific J Cancer Prev, 3, 273-278.

Tajima, K. and Moore, M.A. (2002) Programs for Asian Pacific cancer prevention inresponse to the Four Strategic Directions ofUICC for the New Millennium. AsianPacific J Cancer Prev, 3, 263-266.

Moore, M.A. and Tokudome, S. (2002) Primary cancer prevention in thepost-genomic era. Asian Pacific J Cancer Prev, 3, 183-184.

Tokudome, S., Tokudome, Y. and Moore, M.A. (2002) Dietary iodine sources otherthan fish. Eur J Clin Nutr, 56,467-468.

Tsuda, H. and Moore, M.A. (2002) Cancer screening: a review with particularattention to areas for future international research efforts. Asian Pacific J CancerPrev,3,99-123.

Moore MA 10

Tajima, K., Tsuda, H. and Moore, M.A. (2002) Requirement for Asian Pacificcollaboration in assessment of nutritional factors impacting on cancer development.Asian Pacific J Cancer Prev, 3, 93-96.

Sagae, S., Mori, M. and Moore, M.A. (2002). Risk factors for ovarian cancers: dosubtypes require separate treatment in epidemiological studies? Asian Pacific JCancer Prev, 3, 5-16.

Tajima, K., Tsuda, H. and Moore, M.A. (2002) The contribution of Asian countries tothe international cancer prevention effort - reflections from a glance at the literature.Asian Pacific J Cancer Prev, 3, 1-2.

Tokudome, S., Kuriki, K. and Moore, M.A. (2001) Seaweed and cancer prevention.Jpn J Cancer Res., 92, 1008-9.

Tajima, K. and Moore, M.A. (2001) Screening efficacy in Asia - what of problems ofnon-presentation at hospital for treatment? Asian Pacific J Cancer Prev, 2, 237-239.

Tajima, K. and Moore, M.A. (2001) Postponement of the 2001 APOCP conference­apologies and overcoming a setback - making the APJCP available to libraries ofmedical universities and research institutes across the region. Asian Pacific JCancer Prev, 2, 157-158.

Moore, M.A. (2001) Conclusions from smoking-related research published in theAPJCP in 2000 with a brief review of the literature Asian Pacific J Cancer Prev, 2,147-153.

Tajima, K. and Moore, M.A. (2001) Risk and beneficial factors - fallacy at theindividual but not the population level? Relevance to a Practical PreventionProgram. Asian Pacific J Cancer Prev, 2,83-87.

Moore, M.A. and Tatematsu M. (2001) Are the phenotypes of pre neoplastic lesions ofsignificance for cancer prevention? 1. Liver. Asian Pacific J Cancer Prev, 2, 27-42.

Tajima, K. and Moore, M.A. (2001) What about editorial policy? - important oddsand ends at the start of 200 1.Asian Pacific J Cancer Prev, 2, 1-2.

Park CB, Kim DJ, Moore MA, Takasuka N, Tsuda H. (2000) Promotion of liverlesion development in the Syrian hamster by dietary fat following multi-organinitiation is inhibited by DHEA-S administration. Asian Pacific J Cancer Prev, 1,329-332.

Moore, M.A. (2000) Whats in a name? Cell death - apoptosis and oncosis. AsianPacific J Cancer Prev, 1, 259-260.

Tsuda, H., Sekine, K., Ushida, Y., Kuhara, T., Takasuka, N., Iigo, M., Han, B.S. andMoore MA. ( 2000) Milk and dairy products in cancer prevention: focus on bovinelactoferrin. Mutat Res, 462, 227-233.

MooreMA 11

Moore, M.A. (2000) Psychology and rejection of the habit. Asian Pacific J CancerPrev, 1, 171-174.

Moore, M.A. (2000) Awash with alcohol in the world of prevention. Asian Pacific JCancer Prev, 1,91-93.

Moore, M.A. and Tokudome, S. (2000) Medical school undergraduate curriculum forcancer prevention. Asian Pacific J Cancer Prev, 1, 87-90.

Mochizuki-Kobayashi, Y. and Moore, M.A. (2000) Tobacco smoking in the AsianPacific - the scope of the problem. Asian Pacific J Cancer Prev, 2, 83-87.

Moore, M.A. (2000) The 1998-1999period in cancer prevention publication: lessonsfor the APJCP in 2000. Asian Pacific J Cancer Prev, 1, 7-11.

Moore, M. A. (ed) (2000) IntroductoryVolume: Cancer Prevention in Tables andFigures. APOCP Press, Nagoya and Bangkok.

Tsuda, H., Park, C.B. and Moore M.A. (1999) ShortlMedium Term CarcinogenicityTests: Simple Initiation-Promotion Assay Systems. In 'The Use of Short- andMedium-term Tests for Carcinogens and Data on Genetic Effects in CarcinogenicHazard Evaluation' Eds D.B. McGregor, J.M. Rice, S. Venitt. pp 203-250, IARCPublications No 146. Lyon.

Moore, M.A., Tsuda, H., Tamano, S., Hagiwara, A., Imaida, K., Shirai, T. and Ito,N.(1999). Marriage of a medium-term liver model to surrogate markers - a practicalapproach for risk and benefit assessment. Toxicol Pathol, 27, 237-242.

Moore, M.A., Kunimoto, T. and Tsuda, H. (1999).Country comparisons provideevidence of links between specific circulatory disease and gastric, rectal, prostateand breast cancers. Eur J Cancer Prev, 8, 151-157.

Moore, M.A., Kunimoto, T., Takasuka, N., Park, C.B. and Tsuda, H.(1999) Europeanregistry comparisons provide evidence of renal and colon as well as gallbladdercancer development. Eur J Cancer Prev, 8, 137-146.

Moore, M.A., Kunimoto, T., Takasuka, N., Park, C.B. and Tsuda, H. (1999)Cross-country comparisons of colon and rectal cancer mortality suggest theexistence of differences in risk factors in eastern and western Europe. Eur J CancerPrev, 8, 67-71.

Moore, M.A., Kunimoto, T. and Tsuda, H. (1999) Do cancer associations at thecountry level point to shared risk factors - a fuzzy concept? Eur JCancer Prev, 8,63-65.

Moore MA 12

Moore, M.A., Kunimoto, T., Takasuka, N., Park, C.B. and Tsuda, H.(1999).Cross-country comparisons provide evidence of a hormonal involvement in malelung adenocarcinoma development. Lung Cancer, 24, 99-106.

Moore, M.A. and Tsuda, H. (1999) Cancer screening: an educational challenge. Eur.J. Cancer Prev, 8, 7-16.

Moore, M.A., and Tsuda, H. (1999) Factors influencing library penetration of cancerresearch-associated journals in Japanese universities and research institutions. Jpn.J. Cancer Res., 90,361-364.

Moore, M.A., Park, C.B. and Tsuda, H. (1998) Soluble and insoluble fiber influenceson cancer development. Crit Rev Hematol Oneal, 27,229-242.

Moore, M.A. and Tsuda, H. (1998) Insulin sensitizers - a promising group of cancerpreventive agents? Cancer J, 11, 72-75.

Moore, M.A., Thamavit, W., Tiwawech, D., Ito, N. and Tsuda, H. (1998) ModulationofDHPN-induced liver lesion development in Opisthorchis-infected Syrianhamsters by Praziquantel treatment in association with DHEA administration. Jpn JCancer Res, 89, 1113-1117.

Moore, M.A., Kunimoto, T., Park, C.B. Takasuka, N., and Tsuda, H. (1998) Europeancountry comparisons provide evidence of a link between colon cancer andadenocarcinoma development in the lung but not the oesophagus. Eur J CancerPrev, 7,473-478.

Moore, M.A. and Tsuda H (1998). Co-ordination and ecology in practical cancerprevention. Eur J Cancer Prev, 7,409-415.

Moore, M.A. and Tsuda, H (1998). Proliferation as the key to cancer development.Eur J Cancer Prev, 7, 353-385.

Moore, M.A. and Tsuda, H (1998). Pathophysiological epidemiology - an areademanding greater exploitation for international efforts at cancer control? Eur JCancer Prev, 7, 349-50.

Moore, M.A., Park, c.B. and Tsuda, H (1998). Physical exercise: a pillar for cancerprevention? Eur J Cancer Prev, 7, 177-193.

Moore, M.A., Park, C.B. and Tsuda, H. (1998) Implications of thehyperinsulinemia-diabetes-cancer link for preventive efforts. Eur J Cancer Prev, 7,89-107.

Moore, M.A., Kunimoto, T., Takasuka, N., Park, c.s. and Tsuda, H (1998).Cross-country comparisons provide evidence of a hormonal involvement in femalelung adenocarcinoma development. Cancer J, 11, 259-262.

Moore MA 13Tsuda H, Sekine K, Nakamura J, Ushida Y, Kuhara T, Takasuka N, Kim DJ, Asamoto

M, Baba-Toriyama H, Moore MA, Nishino H, Kakizoe T (1988). Inhibition ofazoxymethane initiated colon tumor and aberrant crypt foci development by bovinelactoferrin administration in F344 rats. Adv Exp Med BioI, 443, 273-84.

Sekine K, Ushida Y, Kuhara T, Iigo M, Baba-Toriyama H, Moore MA, Murakoshi M,Satomi Y, Nishino H, Kakizoe T, Tsuda H (1997). Inhibition of initiation andearly stage development of aberrant crypt foci and enhanced natural killer activity inmale rats administered bovine lactoferrin concomitantly with azoxymethane.Cancer Lett, 121,211-6.

Suzuki I, Iigo M, Ishikawa C, Kuhara T, Asamoto M, Kunimoto T, Moore MA,Yazawa K, Araki E, Tsuda H (1997). Inhibitory effects of oleic anddocosahexaenoic acids on lung metastasis by colon-carcinoma-26 cells areassociated with reduced matrix metalloproteinase-2 and -9 activities. Int J Cancer,73,607-12.

Sekine K, Watanabe E, Nakamura J, Takasuka N, Kim DJ, Asamoto M, KrutovskikhV, Baba-Toriyama H, Ota T, Moore MA, Masuda M, Sugimoto H, Nishino H,Kakizoe T, Tsuda H (1997). Inhibition ofazoxymethane-initiated colon tumor bybovine lactoferrin administration in F344 rats. Jpn J Cancer Res, 88, 523-6.

Thamavit W, Tiwawech D, Moore MA, Ito N, Shirai T (1996). Equivocal evidence ofcomplete carcinogenicity after repeated infection of Syrian hamsters withOpisthorchis viverrini. Toxicol Pathol, 24, 493-7.

Moore MA, Thamavit W, Bannasch P (1996). Tumours of the liver. IARC Sci Publ,126, 79-108.

Thamavit W, Moore MA, Sirisinha S, Shirai T, Ito N (1993). Time-dependentmodulation of liver lesion development in Opisthorchis-infected Syrian hamster byan antihelminthic drug, praziquantel. Jpn J Cancer Res, 84, 135-8.

Thamavit W, Moore MA, Ruchirawat S, Ito N (1992). Repeated exposure toOpisthorchis viverrini and treatment with the antihelminthic Praziquantellackscarcinogenic potential. Carcinogenesis, 13, 309-11.

Thamavit W, Moore MA, Ruchirawat S, Ito N (1992). Lack of modulation effects ofpraziquantel on DMN-induced lesion development in the Syrian hamster liver.Cancer Lett, 61, 229-32.

Thornton M, Moore MA, Ito N (1989). Modifying influence ofdehydro-epiandrosterone or butylated hydroxytoluene treatment on initiation anddevelopment stages of azaserine-induced acinar pancreatic preneoplastic lesions inthe rat. Carcinogenesis, 10,407-10.

Moore MA, Weber E, Mayer D, Bannasch P (1989). Adrenal cortical foci and nodulesin Sprague-Dawley rats treated with N-nitrosomorpholine. Light and electronmicroscopic findings. VirchowsArch B Cell Pathol Inc! Mol Pathol, 57, 91-7.

Moore MA 14

Mayer D, Weber E, Moore MA, Letsch I, Filsinger E, Bannasch P (1988).Dehydroepiandrosterone induced alterations in rat liver carbohydrate metabolism.

Carcinogenesis, 9, 2039-43.

Moore MA, Weber E, Thornton M, Bannasch P (1988). Sex-dependent,tissue-specific opposing effects of dehydroepiandrosterone on initiation andmodulation stages of liver and lung carcinogenesis induced bydihydroxy-di-n-propylnitrosamine in F344 rats.

Carcinogenesis, 9, 1507-9.

Thamavit W,Moore MA, Hiasa Y, Ito N (1988). Related Articles, LinksGeneration of high yields of Syrian hamster cholangiocellular carcinomas andhepatocellular nodules by combined nitrite and aminopyrine administration andOpisthorchis viverrini infection. Jpn J Cancer Res, 79, 909-16.

Weber E, Moore MA, Bannasch P (1988). Phenotypic modulation ofhepatocarcinogenesis and reduction in N-nitrosomorpholine-inducedhemangiosarcoma and adrenal lesion development in Sprague-Dawley rats bydehydroepiandrosterone. Carcinogenesis, 9, 1191-5.

Moore MA, Thamavit W, Hiasa Y, Ito N (1988). Related Articles, LinksEarly lesions induced by DHPN in Syrian golden hamsters: influence of concomitantOpisthorchis infestation, dehydroepiandrosterone or butylated hydroxyanisoleadministration.Carcinogenesis, 9, 1185-9.

Weber E, Moore MA, Bannasch P (1988). Enzyme histochemical and morphologicalphenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liverafter combined treatment with dehydroepiandrosterone and N-nitrosomorpholine.Carcinogenesis, 9, 1049-54.

Thamavit W,Moore MA, Hiasa Y, Ito N (1988). Enhancement ofDHPN inducedhepatocellular, cholangiocellular and pancreatic carcinogenesis by Opisthorchisviverrini infestation in Syrian golden hamsters. Carcinogenesis, 9, 1095-8.

Tsuda H,Moore MA, Asamoto M, Inoue T, Ito N, Satoh K, Ichihara A, Nakamura T,Amelizad Z, Oesch F (1988). Effect of modifying agents on the phenotypicexpression of cytochrome P-450, glutathione S-transferase molecular forms,microsomal epoxide hydrolase, glucose-6-phosphate dehydrogenase andgamma-glutamyltranspeptidase in rat liver preneoplastic lesions. Carcinogenesis, 9,547-54.

Moore MA, Nakagawa K, Ishikawa T (1988). Selection pressure and alteredhepatocellular islands after a single injection of aflatoxin B1.Jpn J Cancer Res, 79,187-94.

Klimek F,Moore MA, Schneider E, Bannasch P (1988). Histochemical andmicrobiochemical demonstration of reduced pyruvate kinase activity inthioacetamide-induced neoplastic nodules ofrat liver. Histochemistry, 90, 37-42.

Moore MA 15

Moore MA, Weber E, Bannasch P (1988). Modulating influence ofdehydroepiandrosterone administration on the morphology and enzyme phenotypeof dimethylaminoazobenzene-induced hepatocellular foci and nodules. VirchowsArch B Cell Pathol Inc! Mol Pathol, 55, 337-43.

Thamavit W, Ngamying M, Boonpucknavig V, Boonpucknavig S, Moore MA (1987).Enhancement of DEN-induced hepatocellular nodule development by Opisthorchisviverrini infection in Syrian golden hamsters. Carcinogenesis, 8, 1351-3.

Moore MA, Makino T, Tsuchida S, Sato K, Ichihara A, Amelizad Z, Oesch F,Konishi Y (1987). Altered drug metabolizing potential of acinar cell lesionsinduced in rat pancreas by hydroxyaminoquinoline l-oxide, Carcinogenesis, 8,1089-94.

Tsuda H, Moore MA, Asamoto M, Inoue T, Fukushima S, Ito N, Satoh K, AmelizadZ, Oesch F (1987). Immunohistochemically demonstrated altered expression ofcytochrome P-450 molecular forms and epoxide hydrolase inN-ethyl-N-hydroxyethylnitrosamine-induced rat kidney and liver lesions.Carcinogenesis, 8, 711-7.

Moore MA, Nakagawa K, Satoh K, Ishikawa T, Sato K (1987). Single GST-Ppositive liver cells--putative initiated hepatocytes. Carcinogenesis, 8, 483-6.

Moore MA, Thamavit W, Ito N (1987). Comparison of lesions induced in the Syriangolden hamster by diethylnitrosamine, dimethylhydrazine, and dibutylnitrosamine:influence of subsequent butylated hydroxyanisole treatment. JNatl Cancer Inst,78,295-301.

Moore MA, Tsuda H, Thamavit W, Masui T, Ito N (1987).Differential modificationof development of preneoplastic lesions in the Syrian golden hamster initiated witha single dose of2,2'-dioxo-N-nitrosodipropylamine: influence of subsequentbutylated hydroxyanisole, alpha-tocopherol, or carbazole. JNatl Cancer Inst,78,289-93.

Thamavit W, Kongkanuntn R, Tiwawech D, Moore MA (1987). Level ofOpisthorchis infestation and carcinogen dose-dependence of cholangiocarcinomainduction in Syrian golden hamsters. VirchowsArch B Cell Pathol Inc! Mol Pathol,54,52-8.

Moore MA, Tsuda H, Hacker HJ, Sato K, Bannasch P, Ito N (1987). Altered enzymeexpression in propylnitrosamine-induced Syrian hamster lung lesions. VirchowsArch B Cell Pathol Inc! Mol Pathol, 54,272-8.

Moore MA, Bannasch P, Satoh T, Hacker HJ, Ito N (1987). Immunohistochemicallydemonstrated increase in glutathione S-transferase species inpropylnitrosamine-induced focal proliferative and neoplastic Syrian hamsterpancreatic lesions. VirchowsArch B Cell Pathol Inc!Mol Pathol, 54,479-88.

Moore MA 16

Moore MA, Nakamura T, Ito N (1986). Immunohistochemically demonstratedglucose-6-phosphate dehydrogenase, gamma-glutamyl transpeptidase, ornithinedecarboxylase and glutathione S-transferase enzymes: absence of direct correlationwith cell proliferation in rat liver putative pre-neoplastic lesions. Carcinogenesis, 7,1419-24.

Moore MA, Nakamura T, Thamavit W, Ichihara A, Ito N (1986).Immunohistochemically demonstrated suppressed expression of tryptophanoxygenase, a marker for liver differentiation, within putative preneoplastic rat liverlesions. Carcinogenesis, 7, 1393-6.

Moore MA, Thamavit W, Ichihara A, Sato K, Ito N (1986). Influence ofdehydroepiandrosterone, diaminopropane and butylated hydroxyanisole treatmentduring the induction phase of rat liver nodular lesions in a short-term system.Carcinogenesis, 7, 1059-63.

Obara T, Makino T, Ura H, Yokose Y, Kinugasa T, Moore MA, Sato K, Konishi Y(1986). Comparative histochemical investigation of the glutathione S-transferaseplacental form and gamma-glutamyltranspeptidase duringN-nitrosobis(2-hydroxypropyl)amine-induced pancreatic carcinogenesis inhamsters. Carcinogenesis, 7, 801-5.

Moore MA, Tsuda H, Ito N (1986). Dehydrogenase histochemistry ofN-ethyl-N-hydroxyethylnitrosamine-induced focal liver lesions in the rat--increasein NADPH-generating capacity. Carcinogenesis, 7, 339-42.

Moore MA, Nakamura T, Shirai T, IchiharaA, Ito N (1986). Immunohistochemicaldemonstration of increased glucose-6-phosphate dehydrogenase in preneoplasticand neoplastic lesions induced by propylnitrosamines in F344 rats and Syrianhamsters. JpnJCancer Res,77, 131-8.

Moore MA, Thamavit W, Tsuda H, Ito N (1986). The influence of subsequentdehydroepiandrosterone, diaminopropane, phenobarbital, butylated hydroxyanisoleand butylated hydroxytoluene treatment on the development of preneoplastic andneoplastic lesions in the rat initiated with di-hydroxy-di-n-propyl nitrosamine.Cancer Lett, 30, 153-60.

Moore MA, Thamavit W, Tsuda H, Sato K, Ichihara A, Ito N (1986). Modifyinginfluence of dehydroepiandrosterone on the development ofdihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver ofF344 rats. Carcinogenesis, 7, 311-6.

Moore MA, Kitagawa T (1986). Hepatocarcinogenesis in the rat: the effect ofpromoters and carcinogens in vivo and in vitro. Int Rev Cytol, 101, 125-73.

Moore MA, Fukushima S, Ichihara A, Sato K, Ito N (1986). Intestinal metaplasia andaltered enzyme expression in propylnitrosamine-induced Syrian hamstercholangiocellular and gallbladder lesions. VirchowsArch B Cell Pathol Inc! MolPathol, 51, 29-38.

Moore MA 17

Tsuda H, Moore MA, Asamoto M, Satoh K, Tsuchida S, Sato K, Ichihara A, Ito N(1985). Comparison of the various forms of glutathione S-transferase withglucose-6-phosphate dehydrogenase and gamma-glutamyltranspeptidase as markersof preneoplastic and neoplastic lesions in rat kidney induced byN-ethyl-N-hydroxyethylnitrosamine.Jpn J Cancer Res,76, 919-29.

Moore MA, Satoh K, Kitahara A, Sato K, Ito N (1985). A protein cross-reactingimmunohistochemically with rat glutathione S-transferase placental form as amarker for preneoplasia in Syrian hamster pancreatic and hepatocarcinogenesis. JpnJCancer Res,76, 1-4.

Moore MA, Tsuda H, Ogiso T, Mera Y, Ito N (1984). Enhancement of phenotypicinstability by alpha-difluoromethylomithine and butylated hydroxyanisole in rapidlyinduced rat liver lesions. Cancer Lett, 25, 145-51.

Tsuda H, Hasegawa R, Imaida K, Masui T,Moore MA, Ito N (1984). Modifyingpotential of thirty-one chemicals on the short-term development of gamma-glutamyltranspeptidase-positive foci in diethylnitrosamine-initiated rat liver. Gann, 75,876-83.

Ito N, Moore MA, Bannasch P (1984). Modification of the development ofN-nitrosomorpholine-induced hepatic lesions by 2-acetylaminofluorene,phenobarbital and 4,4'-diaminodiphenylmethane: a sequential histological andhistochemical analysis.

Carcinogenesis, 5, 335-42.

Moore MA, Hacker HJ, Bannasch P (1983). Phenotypic instability in focal andnodular lesions induced in a short term system in the rat liver. Carcinogenesis, 4,595-603.

Moore MA, Takahashi M, Ito N, Bannasch P (1983). Early lesions during pancreaticcarcinogenesis induced in the Syrian hamster by DHPN or DOPN. II. Ultrastructuralfindings. Carcinogenesis, 4, 439-48.

Mayer D,Moore MA, Bannasch P (1983). Influence of phenobarbital on glycogenmetabolism of rat liver pretreated with N-nitrosomorpholine. Carcinogenesis, 4,931-3.

Moore MA, Takahashi M, Ito N, Bannasch P (1983). Early lesions during pancreaticcarcinogenesis induced in Syrian hamster by DHPN or DOPN. I. Histologic,histochemical and radioautographic findings. Carcinogenesis, 4, 431-7.

Moore MA, Hacker HJ, Kunz HW, Bannasch P (1983). Enhancement ofNNM-induced carcinogenesis in the rat liver by phenobarbital: a combinedmorphological and enzyme histochemical approach. Carcinogenesis, 4, 473-9.

MooreMA 18

Moore MA, Mayer D, Bannasch P (1982). The dose dependence and sequentialappearance of putative preneoplastic populations induced in the rat liver by stopexperiments with N-nitrosomorpholine. Carcinogenesis, 3,1429-36.

Flaks B,Moore MA, Flaks A (1982). Ultrastructural analysis of pancreaticcarcinogenesis. VI. Early changes in hamster acinar cells induced byN-nitroso-bis(2-hydroxypropyl)amine. Carcinogenesis, 3, 1063-70.

Flaks B,Moore MA, Flaks A (1982). Ultrastructural analysis of pancreaticcarcinogenesis. V. Changes in differentiation of acinar cells during chronictreatment with N-nitrosobis(2-hydroxypropyl)amine. Carcinogenesis, 3, 485-98.

Hacker HJ, Moore MA, Mayer D, Bannasch P (1982). Correlative histochemistry ofsome enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesionsin the rat liver. Carcinogenesis, 3, 1265-72.

Flaks B,Moore MA, Flaks A (1981). Ultrastructural analysis of pancreaticcarcinogenesis. IV. Pseudoductular transformation of acini in the hamster pancreasduring N-nitroso-bis(2-hydroxypropyl)amine carcinogenesis. Carcinogenesis, 2,1241-53.

Flaks A,Moore MA, Flaks B (1980). Ultrastructural analysis of pancreaticcarcinogenesis. II. Establishment and morphology of a transplantable hamsterpancreatic adenocarcinoma, FCP. Carcinogenesis, 1, 513-22.

Flaks B,Moore MA, Flaks A (1980). Ultrastructural analysis of pancreaticcarcinogenesis: morphological characterization ofN-nitroso-bis(2-hydroxypropyl)amine-induced neoplasms in the Syrian hamster.Carcinogenesis, 1, 423-38.